NOVN.SW Forward P/E

As of 2025-07-11, the Forward P/E of Novartis AG (NOVN.SW) is 14.21.

Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.